Radioiodinated phospholipid ether analogues

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 165, 424 185, A61K 5100, A61M 3614

Patent

active

057955611

ABSTRACT:
Novel radioiodinated analogues of naturally-occurring phospholipid ethers are tumor-specific and have a triglycerol backbone structure which, in certain embodiments, is substituted at the 3-position with an alkyl phosphocholine and include a monoiodinated benzoyl side chain substituted at the 2-position in accordance with the general formula: ##STR1## where n=1-15 ##STR2## M=0-15; Z=.sup.123 I, .sup.125 I, and .sup.131 I; Y=NH.sub.2, NR.sub.2, and NR.sub.3, and R=alkyl, aralkyl.

REFERENCES:
patent: 3716631 (1973-02-01), Steggerda et al.
patent: 4473544 (1984-09-01), Maehulla et al.
patent: 4571332 (1986-02-01), Schroit et al.
patent: 4925649 (1990-05-01), Counsell et al.
patent: 4965391 (1990-10-01), Counsell et al.
patent: 5061626 (1991-10-01), Baldo et al.
patent: 5087721 (1992-02-01), Counsell et al.
patent: 5347030 (1994-09-01), Counsell et al.
Andreesen et al., Cancer Research, vol. 38, pp. 3894-3899, Nov., 1978.
March et al., Advanced Organic Chemistry, p. 1100, 1985.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Radioiodinated phospholipid ether analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radioiodinated phospholipid ether analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioiodinated phospholipid ether analogues will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1112431

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.